← Back to Clinical Trials
Recruiting NCT03313687
SafeTy and Outcome of contemPorary Treatment Strategies for Cardiogenic SHOCK
Trial Parameters
Condition Cardiogenic Shock
Sponsor Universitätsklinikum Hamburg-Eppendorf
Study Type OBSERVATIONAL
Phase N/A
Enrollment 2,500
Sex ALL
Min Age 18 Years
Max Age N/A
Start Date 2017-09-01
Completion 2030-12-31
Brief Summary
International, observational registry to investigate the outcome in patients with cardiogenic shock. The primary aim of this study is to investigate the clinical outcome of patients in cardiogenic shock.
Eligibility Criteria
Inclusion Criteria: * Patients with cardiogenic shock treated at a tertiary care hospital. Exclusion Criteria: * Age ≤17 years.
Related Trials
NCT03313687
SafeTy and Outcome of contemPorary Treatment Strategies for Cardiogenic SHOCK
View Trial →
NCT05168462
Clinical Outcome and Cost-effectiveness of Reduced Noradrenaline by Using a Lower Blood Pressure Tar
View Trial →
NCT06535503
Clinical Characteristics and Outcomes Among STEMI Patients With Cardiogenic Shock at Abu Dhabi City
View Trial →